Literature DB >> 35358417

Glycopeptidolipid glycosylation controls surface properties and pathogenicity in Mycobacterium abscessus.

Wassim Daher1, Louis-David Leclercq2, Matt D Johansen3, Claire Hamela4, Jona Karam4, Xavier Trivelli5, Jérôme Nigou6, Yann Guérardel7, Laurent Kremer8.   

Abstract

Mycobacterium abscessus is an emerging and difficult-to-manage mycobacterial species that exhibits smooth (S) or rough (R) morphotypes. Disruption of glycopeptidolipid (GPL) production results in transition from S to R and severe lung disease. A structure-activity relationship study was undertaken to decipher the role of GPL glycosylation in morphotype transition and pathogenesis. Deletion of gtf3 uncovered the prominent role of the extra rhamnose in enhancing mannose receptor-mediated internalization of M. abscessus by macrophages. In contrast, the absence of the 6-deoxy-talose and the first rhamnose in mutants lacking gtf1 and gtf2, respectively, affected M abscessus phagocytosis but also resulted in the S-to-R transition. Strikingly, gtf1 and gtf2 mutants displayed a strong propensity to form cords and abscesses in zebrafish, leading to robust and lethal infection. Together, these results underscore the importance and differential contribution of GPL monosaccharides in promoting virulence and infection outcomes.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mycobacterium abscessus; glycopeptidolipid; glycosyltransferase; internalization; macrophage; mannose receptor; morphotype; rhamnose; virulence; zebrafish

Mesh:

Substances:

Year:  2022        PMID: 35358417     DOI: 10.1016/j.chembiol.2022.03.008

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   9.039


  1 in total

1.  The ESX-4 substrates, EsxU and EsxT, modulate Mycobacterium abscessus fitness.

Authors:  Marion Lagune; Vincent Le Moigne; Matt D Johansen; Flor Vásquez Sotomayor; Wassim Daher; Cécile Petit; Gina Cosentino; Laura Paulowski; Thomas Gutsmann; Matthias Wilmanns; Florian P Maurer; Jean-Louis Herrmann; Fabienne Girard-Misguich; Laurent Kremer
Journal:  PLoS Pathog       Date:  2022-08-12       Impact factor: 7.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.